Research Scholars Program - Gilead Sciences
Gilead Sciences funds innovative research by emerging investigators to address health inequities in HIV, viral hepatitis, liver disease, and oncology, with a focus on diversity and inclusion.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (annual application deadline, projected)
Funding Amounts: Typically $180,000 USD total over 2 years (paid in annual installments; amounts may vary by region)
Summary: Supports innovative research by emerging investigators, with a focus on diversity and health inequities in HIV, viral hepatitis, liver disease, and oncology.
Key Information: Forecasted cycle—dates and details subject to change; check program site for updates.
Description
The Gilead Sciences Research Scholars Program provides two years of financial support to junior faculty and emerging investigators conducting innovative research in therapeutic areas of unmet medical need. The program is committed to fostering diversity and inclusion in science, reducing barriers for underrepresented groups, and supporting projects that address health inequities. Research focus areas include HIV and viral hepatitis, primary biliary cholangitis, oncology (solid tumors), and liver disease. Selection is overseen by independent scientific review committees to ensure objectivity and integrity.
